Endocrinology Test
|
|
| 1. The confirmatory marker of Graves’ disease is: |
|
|
| 2. In Europe, first-line treatment option in Graves’ disease is: |
|
|
| 3. The best test for diagnosing osteoporosis is: |
|
|
| 4. 21 hydroxylase deficiency: |
|
|
| 5. Which of the following is the principal inhibitor of prolactin: |
|
|
| 6. In case of Cushing disease the clinical picture: |
|
|
| 7. Bone formation agents used as osteoporosis treatment are represented by: |
|
|
| 8. Antiresorptive agents used as osteoporosis treatment are represented by: |
|
|
| 9. Additional lab diagnostic in Cushing disease show: |
|
|
| 10. In case of prolactinoma the endocrine syndrome in males comprise: |
|
|
| 11. Adverse effects of the contraceptives are: |
|
|
| 12. The clinical suggestive features for thyroid malignancy are: |
|
|
| 13. Under the possible effects of growth hormone we can observe: |
|
|
| 14. In primary hyperaldosteronism: |
|
|
| 15. The following are true regarding medical treatment of GH deficiency: |
|
|
| 16. In cortisol –secreting adrenal adenoma: |
|
|
| 17. Causes of secondary hyperaldosteronism: |
|
|
| 18. Hormonal secretion regulation includes: |
|
|
| 19. The differential diagnosis of endogenous hypercorticism includes: |
|
|
| 20. Lab exam in Cushing’s shows: |
|
|
| 21. Combined regulation mechanisms in the endocrine system are: |
|
|
| 22. The endocrine complications of corticotherapy are: |
|
|
| 23. In cases of hypopituitarism the GH supplemental therapy: |
|
|
| 24. Which statements are true: |
|
|
| 25. The physiologic effects of cortisol are represented by: |
|